TcrossGlobal

TAVR with Sapien 3 in Low-Risk Patients: 5-Year Follow-up of the PARTNER 3 Trial

A 5-year follow-up of the PARTNER 3 trial showed no significant difference in the composite outcome of death, stroke, or rehospitalization at 5 years after TAVR and surgery in patients with symptomatic severe aortic stenosis at low surgical risk. Dr. Martin B. Leon of New York-Presbyterian Columbia University Irving Medical Center, presented at the Late-Breaking Clinical Trials session of TCT 2023.

In the PARTNER 3 trial, 1,000 patients with symptomatic severe aortic stenosis with STS scores of &l...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.